La plateforme d’analyses d’imagerie médicale de Zebra Medical Vision, rachetée par Nanox, permet aux établissements de santé de déterminer les patients à risque et d’offrir des parcours de traitement préventif évolués pour améliorer les soins aux patients.
Zebra-Med est financée par Khosla Ventures, Marc Benioff, Intermountain Investment Fund, OurCrowd Qure, Aurum, aMoon, Nvidia, J&J et Dolby Ventures, ainsi que par des chercheurs en IA renommés, à savoir la professeure Fei Fei Le, le professeur Amnon Shashua et Richard Shocher. Zebra Medical Vision a été nommée l’une des cinq principales entreprises en IA et en apprentissage automatique par le magazine Fast Company.
LE PLUS. Israeli medical imaging firm Nanox announced on Tuesday that it will acquire AI medical imaging insights startup Zebra Medical Vision for approximately $200 million in a deal that positions the future combined company as a force in the medical tech industry.
Nanox will pay $100 million upfront for the acquisition, and up to another $100 million tied to achievements of specific milestones, all to be paid in Nanox shares, the companies explained in a statement.
Zebra Medical is expected to be run as a wholly-owned subsidiary under the Nanox brand.
Zebra Medical was founded in 2014 by Eyal Toledano, Eyal Gura, and Elad Benjamin, as an AI solution that reads medical scans and automatically detects anomalies, helping radiologists with workflow and efficiency. Through its development and use of different algorithms, Zebra Medical has been able to identify visual symptoms for diseases such as breast cancer, osteoporosis, and fatty liver as well as conditions such as aneurysms and brain bleeds.
The company has seven FDA clearances for its solutions which are used in hospitals in the US, Europe, Australia, India, and Latin America.
